Delphine Diagnostics Strengthens AI Capabilities for Infection Diagnosis
Delphine Diagnostics continues to advance its mission of improving infection diagnosis and treatment decision support through innovation. Beginning in Q1 2026,...
Read more2025
Delphine Diagnostics Highlights New Jersey’s Growing HealthTech Ecosystem
Delphine Diagnostics continues to support the rapid growth of New Jersey’s healthcare innovation ecosystem through the development of AI-enabled diagnostic...
Read more
Founder Shares Insights on Healthcare Innovation at TiE New Jersey
Delphine Diagnostics’ Founder & CEO, Andy Bala, participated as a panelist at “Shot in the Arm: Pioneering Innovative Startups in Healthcare &...
Read more
Delphine Diagnostics Appoints Raj Devalapalli as Senior Strategic Advisor
Delphine Diagnostics is pleased to announce the appointment of Mr. Raj Devalapalli as Senior Strategic Advisor to the Founder & CEO. A respected pharmaceutical...
Read more
Delphine Diagnostics Participates in TiE New Jersey HealthTech Panel
Delphine Diagnostics participated in a TiE New Jersey HealthTech panel discussion focused on the opportunities and challenges of bringing healthcare innovations to...
Read more
A promising step forward in infection diagnostics
It’s encouraging to see innovative diagnostic solutions like TriVerity from Inflammatix gaining recognition in the U.S. healthcare landscape. Such advancements...
Read more
Founder Joins New Jersey Life Sciences Workforce Leadership Council
Delphine Diagnostics’ Founder & CEO, Andy Bala, was appointed to the New Jersey Life Sciences Industry Partnership Workforce Leadership Council by the New...
Read more
Fueling the Future of Diagnostics: Andy Bala’s Pitch at Silicon Valley Demo Day
Andy Bala is excited to share this update regarding Delphine Diagnostic’s pitch to Investor community at Santa Clara CA, on...
Read more
Delphine Diagnostics to Present at BioNJ BioPartnering Conference 2025
Delphine Diagnostics participated in the BioNJ BioPartnering Conference 2025 at Liberty Science Center, New Jersey, showcasing the company’s vision and innovations in...
Read more
Delphine Diagnostics Receives Maternal and Infant Health R & D Award Grant from the New Jersey Commission on Science Innovation and Technology (NJ CSIT)
Princeton, NJ. March 5, 2025 New Jersey – Delphine Diagnostics, a pioneering company in medical diagnostics, is honored to announce that...
Read moreFollow our latest updates and insights.
For media, partnership, investor, career, or customer inquiries, connect with our team.